Synaptotoxic effects of extracellular tau are mediated by its microtubule-binding region
Acta Neuropathologica · 2025
DOI: 10.1007/s00401-025-02897-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Neuropathologica, 2025. Verfasst von Tomas Ondrejcak und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Therapeutics, School of Medicine, and Institute of Neuroscience, Trinity College, Watts Building, Dublin 2, Ireland. Hauptthemen laut MEDLINE: tau Proteins, Microtubules, Synapses. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Foundation Ireland, University of Dublin, Trinity College.
Abstract (Originalsprache)
Immunotherapies targeting extracellular tau share the premise that interrupting cell-to-cell spread of tau pathology in Alzheimer’s disease (AD) will slow dementia pathogenesis. Whether these interventions affect the actions of synaptotoxic, extracellular tau species that may contribute to cognitive impairment is relatively unknown. Here, we assayed synaptic plasticity disruption in anaesthetised live rats caused by intracerebral injection of synaptotoxic tau present either in (a) secretomes of induced pluripotent stem cell-derived neurons (iNs) from people with Trisomy 21, the most common genetic cause of AD, or (b) aqueous extracts of human AD brain. Extracellular tau in iN secretomes was found to include fragments that contain the extended microtubule-binding regions of tau, MTBR/R’ and adjacent C-terminal sequences. Immunodepletion or co-injection with antibodies targeting epitopes within these fragments prevented the acute disruption of synaptic plasticity by these patient-derived synaptotoxic tau preparations. Moreover, a recombinant human tau fragment encompassing the core MTBR/R’-region present in tau fibrils, tau 297-391 , potently mimicked the deleterious action of patient-derived tau. MTBR/R’-directed antibodies also rapidly reversed a very persistent synaptotoxic effect of soluble brain tau. Our findings reveal a hitherto relatively unexplored potential benefit of targeting extracellular MTBR/R’ tau on correcting synaptic dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Therapeutics, School of Medicine, and Institute of Neuroscience, Trinity College, Watts Building, Dublin 2, Ireland.
- Department of Physiology and Neurobiology, School of Basic Medical Sciences, Zhengzhou University, 100 Science Avenue, Zhengzhou, 450001, China.
- Talisman Therapeutics, Babraham Research Campus, Cambridge, CB22 3AT, UK.
- Laboratory for Neurodegenerative Research, Brigham and Women's Hospital and Harvard, Ann Romney Center for Neurologic Diseases, Medical School, Boston, MA, USA.
- Translational Mass Spectrometry Research Group, University College London Institute of Child Health and Great Ormond Street Hospital, London, UK.
- Gen2 Neuroscience, Babraham Research Campus, Cambridge, CB22 3AT, UK.
Förderung
- Science Foundation Ireland
- University of Dublin, Trinity College
Zitieren
APA
Ondrejcak, T., Hu, N. W., Coode, E., Campbell, T., Corbett, G. T., Doykov, I., Mills, K., Walsh, D. M., Livesey, F. J., Rowan, M. J., & Klyubin, I. (2025). Synaptotoxic effects of extracellular tau are mediated by its microtubule-binding region. Acta Neuropathologica. https://doi.org/10.1007/s00401-025-02897-0
Vancouver
Ondrejcak T, Hu NW, Coode E, Campbell T, Corbett GT, Doykov I, et al. Synaptotoxic effects of extracellular tau are mediated by its microtubule-binding region. Acta Neuropathologica. 2025. doi:10.1007/s00401-025-02897-0
BibTeX
@article{Ondrejcak2025,
author = {Ondrejcak, Tomas and Hu, Neng-Wei and Coode, Emily and Campbell, Tom and Corbett, Grant T and Doykov, Ivan and Mills, Kevin and Walsh, Dominic M and Livesey, Frederick J and Rowan, Michael J and Klyubin, Igor},
title = {Synaptotoxic effects of extracellular tau are mediated by its microtubule-binding region},
journal = {Acta Neuropathologica},
year = {2025},
doi = {10.1007/s00401-025-02897-0}
}
EUVIMED